MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$9.35 0.02 (0.21%)
Open Price: 9.12
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients